A unique case reports primary hepatic angiosarcoma in an adolescent twin with cryptogenic cirrhosis and a germline MAF gene mutation, implicating LSEC dysfunction.
This case report provides the first evidence linking germline MAF variants to liver disease and hepatic angiosarcoma, highlighting the critical role of liver sinusoidal endothelial cells in liver homeostasis.
Absolute Event Rate: 0% vs 0%
Primary hepatic angiosarcoma (HAS) is an exceedingly rare tumor that is often idiopathic and usually fatal. It typically occurs in a bimodal age distribution, in older adults or very young children. We describe a unique case of HAS arising at an unusual age, in an adolescent who was one of a pair of identical twins affected by cryptogenic cirrhosis and who were found to have germline loss-of-function variant in MAF , a gene that has recently been shown through animal models to be crucial in the specification of liver sinusoidal endothelial cells (LSECs). The case is the first known report of liver disease in the setting of germline MAF variants. It implicates LSEC dysfunction in both non-neoplastic and neoplastic liver disease and lends insight into the importance of LSECs in liver health and homeostasis.
Duggan et al. (Mon,) reported a other. A unique case reports primary hepatic angiosarcoma in an adolescent twin with cryptogenic cirrhosis and a germline MAF gene mutation, implicating LSEC dysfunction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: